DKSH has signed an agreement to acquire P.R. Chemicals, a specialties distributor of Active Pharmaceutical Ingredients (APIs) in Thailand. The acquisition strengthens DKSH Performance Materials’ pharmaceutical business, expands its customer reach, and supports further growth in the attractive healthcare sector across Southeast Asia.
Established in 1984 and headquartered in Bangkok, P.R. Chemicals has built a strong reputation as a trusted distributor to pharmaceutical manufacturers across Thailand, serving a broad range of therapeutic areas including pain management, anti-infectives, nutritional health, cardiovascular care, and inflammation.
With a team of 27 highly skilled employees, the company serves a diversified portfolio of more than 100 customers. In 2025, P.R. Chemicals generated net sales of more than CHF 11 million at good profitability.
The acquisition represents an important step in DKSH Performance Materials’ strategy to expand its API platform and strengthen its position in healthcare-related specialty ingredients. P.R. Chemicals complements DKSH’s existing portfolio in Thailand, creating opportunities to broaden customer coverage and deliver additional value through cross-selling as well as an expanded product offering.
DKSH will acquire 100% of P.R. Chemicals and fully integrate the business into its existing operations. The transaction is expected to close in the fourth quarter of 2026, subject to customary closing conditions.
